C4 therapeutics to participate in upcoming march investor conferences

Watertown, mass., feb. 24, 2025 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that c4t management will participate in two upcoming march investor conferences.

CCCC Ratings Summary

CCCC Quant Ranking